Quantcast
Channel: WN.com - Articles related to Noven Receives FDA Approval for Brisdelle™ (Paroxetine) Capsules, the First Nonhormonal Therapy for Vasomotor Symptoms Associated with Menopause
Viewing all articles
Browse latest Browse all 189

Noven wins FDA approval for first non-hormonal drug to treat menopausal symptoms

$
0
0
The U.S. Food and Drug Administration has approved a new, non-hormonal medication for treating hot flashes and night sweats in women that was developed by Miami-based Noven Pharmaceuticals. The medication, called Brisdelle, is the first non-hormonal treatment option for hot flashes and night...

Viewing all articles
Browse latest Browse all 189

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>